PURPLE BIOTECH LTD.
For the period ended Dec 31, 2025. Filed Mar 19, 2026.
View on SEC.govAbout this filing
The yearly report of a company based outside the US. It covers much of what a 10-K does, and may follow accounting rules other than US ones.
FY2025 · Filed Mar 19, 2026
Contents
CODE OF ETHICS
ITEM 16B. CODE OF ETHICS
Our Board adopted a Code of Business Conduct and Ethics (the “Code”) that applies to all our employees, including without limitation our chief executive officer, chief financial officer and controller. Our Code is intended to meet the definition of “code of ethics” under Item 16B of 20-F under the Exchange Act. A copy of the Code may be viewed on our website at www.purple-biotech.com. Information contained on, or that can be accessed through, our website does not constitute a part of this Annual Report on Form 20-F and is not incorporated by reference herein. We will disclose on our website any amendment to, or waiver from, a provision of our Code to the extent required under the rules of the SEC or Nasdaq. There have been no material changes to our Code since our most recent Annual Report Form 20-F.
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.